Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Stomach Neoplasms 2Breast Neoplasms 2Smoldering Multiple Myeloma 1Psychological Well-Being 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Helicobacter Infections 1Fatigue Syndrome, Chronic 1Esophageal Neoplasms 1Diarrhea 1Breast Carcinoma In Situ 1

Interventions

Fulvestrant 58Trastuzumab 49Capecitabine 48Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Anastrozole 25exemestane 24Tamoxifen 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Probiotics × Clear all
NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
308 enrolled
Breast

Breast Neoplasms, Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡